Log In
Print
BCIQ
Print
Print this Print this
 

NPSP795, SB-423562

  Manage Alerts
Collapse Summary General Information
Company NPS Pharmaceuticals Inc.
DescriptionSmall molecule antagonist of the calcium receptor
Molecular Target Calcium sensing receptor (CaSR)
Mechanism of ActionCalcium-sensing receptor (CaSR) antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard Indication Metabolic (unspecified)
Indication DetailsTreat autosomal dominant hypocalcaemia with hypercalciuria (ADHH)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today